Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tema Healthcare AI ETF
(NQ:
HLTH
)
27.57
+0.12 (+0.44%)
Delayed Quote
Updated: 3:06 PM EDT, Oct 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Tema Healthcare AI ETF
< Previous
1
2
Next >
Tema Launches Healthcare AI ETF (HLTH)
July 21, 2026
From
Tema ETFs
Via
Business Wire
Cue Health to Pursue Wind Down of the Business
May 28, 2024
From
Cue Health Inc.
Via
Business Wire
Cue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)
May 13, 2024
From
Cue Health Inc.
Via
Business Wire
Cue Health to Announce First Quarter Financial Results
April 29, 2024
From
Cue Health Inc.
Via
Business Wire
Cue Health Announces Strategic Actions to Position Company for Next Stage
March 20, 2024
From
Cue Health Inc.
Via
Business Wire
Cue Health Reports Fourth Quarter 2023 Financial Results
March 13, 2024
From
Cue Health Inc.
Via
Business Wire
Cue Health to Announce Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024
From
Cue Health Inc.
Via
Business Wire
Cue Health Announces Appointment of Rishi Reddy to Board of Directors
February 16, 2024
From
Cue Health Inc.
Via
Business Wire
Cue Health to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 31, 2024
From
Cue Health Inc.
Via
Business Wire
Cue Health Reports Third Quarter 2023 Financial Results
November 08, 2023
From
Cue Health Inc.
Via
Business Wire
Cue Health to Announce Third Quarter 2023 Financial Results
October 25, 2023
From
Cue Health Inc.
Via
Business Wire
Concerned Stockholders of Cue Health Send Letter to Board
October 06, 2023
From
On behalf of Concerned Stockholders of Cue Health
Via
Business Wire
Peer-Reviewed Independent Study Published in Microbiology Spectrum Finds Cue Health’s Molecular COVID-19 Test is as Accurate as a Lab-Based PCR Test
October 04, 2023
From
Cue Health
Via
Business Wire
Cue Health Adopts Limited-Duration Shareholder Rights Plan
September 21, 2023
From
Cue Health Inc.
Via
Business Wire
Cue Health to Present at Upcoming Investor Conferences
August 23, 2023
From
Cue Health Inc.
Via
Business Wire
Cue Health Reports Second Quarter 2023 Financial Results
August 09, 2023
From
Cue Health Inc.
Via
Business Wire
Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use
August 03, 2023
From
Cue Health Inc.
Via
Business Wire
Cue Health to Announce Second Quarter 2023 Financial Results
July 26, 2023
From
Cue Health Inc.
Via
Business Wire
Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
June 06, 2023
From
Cue Health
Via
Business Wire
Cue Health to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
May 31, 2023
From
Cue Health Inc.
Via
Business Wire
Cue Health Reports First Quarter 2023 Financial Results
May 10, 2023
From
Cue Health Inc.
Via
Business Wire
Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular Test
May 09, 2023
From
Cue Health
Via
Business Wire
Cue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from Home
May 08, 2023
From
Cue Health
Via
Business Wire
Cue Health to Announce First Quarter 2023 Financial Results
April 26, 2023
From
Cue Health Inc.
Via
Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
April 25, 2023
From
The Schall Law Firm
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
April 25, 2023
From
The Schall Law Firm
Via
Business Wire
Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test
March 20, 2023
From
Cue Health
Via
Business Wire
Cue Health Reports Fourth Quarter and Full-Year 2022 Financial Results
March 15, 2023
From
Cue Health Inc.
Via
Business Wire
Cue Health’s New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your Health
March 13, 2023
From
Cue Health
Via
Business Wire
Cue Health Collaborates with Pfizer to Provide People who Test Positive for COVID-19 with Actionable Health Information to Better Inform their Treatment Journey
March 02, 2023
From
Cue Health
Via
Business Wire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
